title: Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
abstract: Professional staff in four state facilities for individuals with mental retardation were surveyed to determine their perceptions, knowledge and opinions regarding the use of psychotropic medication. A large majority of the 377 respondents indicated that the physicians in their facilities were primarily responsible for medication-related decisions. Under ideal conditions, however, all professional staff and parents were seen as having a greater influence in the decision-making process. Aggression, delusions and hallucinations, self-injury, other psychiatric disorders, and anxiety were rated as disorders most likely to result in medication therapy. Behaviour modification was viewed as a suitable alternative to drug treatment for acting out and aggression. The professionals indicated that behavioural observation was the most influential assessment technique in current usage, followed by global impressions and informal diaries. Over 80% of the respondents perceived their preservice and inservice training on issues related to the use of psychotropic medication to treat behaviour problems as inadequate, with 96% of them desiring continuing education. These findings were compared to data from similar studies of populations with other disabilities, and suggestions for modifications in the current decision-making processes related to the use of psychotropic medication in institutionalized individuals with mental retardation are discussed.
authors.affiliation: Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0489, USA.
authors.forename: N N
authors.initials: NN
authors.lastname: Singh
authors.forename: C R
authors.initials: CR
authors.lastname: Ellis
authors.forename: L S
authors.initials: LS
authors.lastname: Donatelli
authors.forename: D E
authors.initials: DE
authors.lastname: Williams
authors.forename: R W
authors.initials: RW
authors.lastname: Ricketts
authors.forename: A B
authors.initials: AB
authors.lastname: Goza
authors.forename: N
authors.initials: N
authors.lastname: Perlman
authors.forename: D E
authors.initials: DE
authors.lastname: Everly
authors.forename: A M
authors.initials: AM
authors.lastname: Best
authors.forename: Y N
authors.initials: YN
authors.lastname: Singh
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003657:Decision Making / Q000187:drug effects; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology*; D008605:Mental Health Services; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D012112:Residential Facilities; D011795:Surveys and Questionnaires; D000078329:Workforce
chemical_list: D011619:Psychotropic Drugs